Abstract:Lipid based nanoparticulate formulations have been widely used for the encapsulation and sustain release of hydrophilic drugs, but they still face challenges such as high initial burst release. Nanolipogel (NLG) emerges as a potential system to encapsulate and deliver hydrophilic drug while suppressing its initial burst release. However, there is a lack of characterization of the drug release mechanism from NLGs. In this work, we present a study on the release mechanism of hydrophilic Dextran-Fluorescein Isothiocyanate (DFITC) from Poly (ethylene glycol) Diacrylate (PEGDA) NLGs by using different molecular weights of PEGDA to vary the mesh size of the nanogel core, drawing inspiration from the macromolecular crowding effect in cells, which can be viewed as a mesh network of undefined sizes. The effect is then further characterized and validated by studying the diffusion of DFITC within the nanogel core using Fluorescence Recovery after Photobleaching (FRAP), on our newly developed cell derived microlipogels (MLG). This is in contrast to conventional FRAP works on cells or bulk hydrogels, which is limited in our application. Our work showed that the mesh size of the NLGs can be controlled by using different Mw of PEGDA, such as using a smaller MW to achieve higher crosslinking density, which will lead to having smaller mesh size for the crosslinked nanogel, and the release of hydrophilic DFITC can be sustained while suppressing the initial burst release, up to 10-fold more for crosslinked PEGDA 575 NLGs. This is further validated by FRAP which showed that the diffusion of DFITC is hindered by the decreasing mesh sizes in the NLGs, as a result of lower mobile fractions. These findings will be useful for guiding the design of PEGDA NLGs to have different degree of suppression of the initial burst release as well as the cumulative release, for a wide array of applications. This can also be extended to other different types of nanogel cores and other nanogel core-based nanoparticles for encapsulation and release of hydrophilic biomolecules.

Sustained Release of Hydrophobic Drugs by the Microfluidic Assembly of Multistage Microgel/poly (Lactic-Co-glycolic Acid) Nanoparticle Composites

Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery

Injectable Alginate Microsphere/plga–peg–plga Composite Hydrogels for Sustained Drug Release

Biodegradable Strain-Promoted Click Hydrogels for Encapsulation of Drug-Loaded Nanoparticles and Sustained Release of Therapeutics

Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug

Microfluidic preparation of monodisperse PLGA-PEG/PLGA microspheres with controllable morphology for drug release.

Microfluidic Preparation of Microparticles Capable of Sustained Release of Nanoparticles

Microfluidic-Based Preparation of Plga Microspheres Facilitating Peptide Sustained-Release

A Tough Composite Hydrogel Can Controllably Deliver Hydrophobic Drugs under Ultrasound

Supramolecular nanoarchitectonics of phenolic-based nanofiller for controlled diffusion of versatile drugs in hydrogels

Well-designed Microcapsules Fabricated Using Droplet-Based Microfluidic Technique for Controlled Drug Release

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

Composite Core-Shell Microparticles from Microfluidics for Synergistic Drug Delivery

Development of a biocompatible and biodegradable hybrid hydrogel platform for sustained release of ionic drugs

Ultra-Long-Term Delivery of Hydrophilic Drugs Using Injectable In Situ Cross-Linked Depots

Characterizing the drug release from the hydrogel drug delivery system incorporated with biodegradable microspheres

Cell-mimicking polyethylene glycol-diacrylate based nanolipogel for encapsulation and delivery of hydrophilic biomolecule

Novel Preparation Method for Sustained-Release Plga Microspheres Using Water-In-Oil-In-Hydrophilic-Oil-In-Water Emulsion

Tunable Amphiphilic Poly(Ether-Anhydride) Gel Nanoparticles for the Delivery of Hydrophobic Drugs

Injectable Hydrogels for Programmable Nanoparticle Release

Polysaccharides/mesoporous silica nanoparticles hybrid composite hydrogel beads for sustained drug delivery